News

KP Tissue Inc. Completes Senior Unsecured Notes Offering successfully

KP Tissue Inc. Completes Senior Unsecured Notes Offering successfully

KP Tissue Inc. Successfully Closes Senior Unsecured Notes Offering

KP Tissue Inc. (KPT) recently announced the successful closure of a significant offering of senior unsecured notes. This financing effort marks a pivotal step for Kruger Products Inc. (KPI), involved in this strategic move to bolster its financial stability and operational capabilities.

Details of the Offering

KPI issued a total of CDN $165 million in principal amount of 6.250% Senior Unsecured Notes. The maturity of these notes is set for December 10, 2032. Interest payments will be made semi-annually starting June 10, 2026. The proceeds from this offering will enable KPI to address its existing financial obligations while also repositioning itself for growth.

Utilization of Proceeds

A substantial portion of the funds raised will be allocated to repay the outstanding borrowings associated with the senior credit facilities of Kruger Products SB Inc. (KPSB). This move is expected to provide KPI with a more robust balance sheet to support its operational strategies. The remaining funds will be employed for general corporate purposes, allowing KPI to invest further in its ongoing projects and initiatives.

Amendments to Credit Agreement

In conjunction with the offering, the existing syndicated credit agreement was amended and restated. This amendment increases the total facility amount from CDN $230 million to CDN $250 million and expands the accordion feature from CDN $75 million to CDN $100 million. This adjustment ensures that KPI is positioned to leverage additional capital as needed.

About KP Tissue Inc.

KP Tissue Inc. was established with the purpose of holding equity interest in KPI, which is reflected in its investment management strategy. Currently, KPT holds a 12.1% interest in KPI, signifying a substantial commitment to supporting KPI’s vision and operational goals.

About Kruger Products Inc.

KPI stands as Canada’s foremost manufacturer of tissue products quality renowned for serving both household and commercial markets. With a diverse portfolio including popular brands like Cashmere, Purex, SpongeTowels, Scotties, and Bonterra, KPI effectively meets the wide-ranging needs of consumers. Furthermore, KPI extends its manufacturing capabilities in the U.S. through the White Cloud brand along with various private labels. The Away-From-Home division concentrates on offering innovative and cost-effective solutions tailored for commercial and public sectors.

Future Directions

The management at KPI is optimistic about how these changes will shape the company’s future. By strategically utilizing the funds generated through the recent notes offering, KPI aims to enhance its operations and further its market reach. Ensuring that they remain adaptable to market conditions is essential for KPI as it navigates its growth trajectory.

Company Contacts

If you have any queries or require further information, please feel free to reach out:

François Paroyan
General Counsel and Corporate Secretary
905-812-6936
francois.paroyan@krugerproducts.ca

Doris Grbic
Director, Investor Relations
437-882-2596
ir@krugerproducts.ca

Frequently Asked Questions

What are the key highlights of the recent notes offering?

The offering raised CDN $165 million at a 6.250% interest rate, maturing in 2032, aimed at strengthening KPI’s financial position.

How will the proceeds from the notes be used?

Proceeds will repay senior credit borrowings and support general corporate purposes, strengthening KPI's balance sheet.

What amendments were made to the credit agreement?

The credit agreement was amended to increase the facility limit to CDN $250 million and change the accordion feature limit to CDN $100 million.

What is the role of KP Tissue Inc. in Kruger Products?

KP Tissue Inc. primarily holds equity interests in Kruger Products, reflecting a significant stake in the operations and future prospects of the company.

What is the market position of Kruger Products Inc.?

KPI is considered Canada’s leading tissue product manufacturer, recognized for quality and a strong range of household and commercial brands.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Arch Biopartners Secures Funding Through Private Placement

Updated Category News Views 147

Arch Biopartners Announces Private Placement to Enhance Growth Arch Biopartners Inc. is excited to share that it has successfully arranged a non-brokered private placement. This offering consists of 225,806 common shares priced at $1.55 each, aiming to raise gross proceeds of $350,000 CAD. This strategic move positions Arch to bolster its working capital, which is...

Continue Reading
Revolutionizing Laboratory Automation: Trilobio's New Platform

Updated Category News Views 376

Trilobio Unveils Comprehensive Lab Automation Platform At the forefront of advancing biology research, Trilobio has introduced a groundbreaking whole lab automation platform at a major conference. This innovative platform integrates robotics, lab equipment, and software, creating a streamlined solution for researchers facing workflow challenges. Transforming Genetic...

Continue Reading
Shell Expands Share Buyback Program with Recent Purchases

Updated Category News Views 61

Shell's Strategic Share Buyback Initiative Shell plc recently announced a significant purchase of shares for cancellation, reaffirming its dedication to enhancing shareholder value. On a specific date, the company acquired a substantial number of shares, a move that is part of the broader share buyback program that was outlined in detail previously. Details of Share...

Continue Reading
Constellium SE to Host Earnings Call for Q3 2024 Results

Updated Category News Views 44

Constellium SE to Share Q3 2024 Financial Update Constellium SE (NYSE: CSTM) is preparing to reveal its third-quarter 2024 results during a special conference call and webcast. This event will occur on a Wednesday morning, aiming to keep stakeholders informed and engaged with the company's latest developments. Details of the Upcoming Conference Call The conference call is...

Continue Reading
Streamline Health Strengthens Partnership with New Contract

Updated Category News Views 133

Expanding Horizons: Streamline Health’s New Contract Streamline Health Solutions, Inc. (NASDAQ: STRM) has recently announced a notable contract for its RevID technology with a health system based in Kentucky. This particular system is a 120-bed facility that utilizes Oracle Health's EHR, marking a significant step in Streamline Health's expansion within the healthcare...

Continue Reading